Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
Learn how functional proteomics is filling the translational gap in single-cell technology
See how Bruker Cellular Analysis' single-cell proteomic data is predicting resistance in tumor cells
Discover how single-cell phosphoproteomics informs targeted combination therapies